News & Events

Read the latest, meet us in person.


Most recent news

Hunterian Medicine® Licenses Inscripta’s MAD7™ Nuclease to Advance Gene Editing Research and Development
Inscripta and Hunterian pioneer new program to provide access to novel CRISPR enzymes for biotherapeutic development…
Read More
Inside the World of Genome Engineering at Amyris with Kirsten Benjamin, VP of R&D
Kirsten Benjamin of Amyris Takes Us into the World of Genome-Wide Engineering Amyris has long been the Bay Area’s crown jewel of synthetic…
Read More
Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx™ Genome Engineering Platform
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and…
Read More


Newton's Cradle: Exploring rational and empirical design space with Engineering Biology
November 16, 2021
Discovery in biological research was historically driven by empirical methods. The advent of biological engineering, propelled by technological…
Learn More And Register
Heterologous Protein Engineering and characterization of native regulatory elements in E. coli using Massively Parallel CRISPR Editing
October 14, 2021
Heterologous protein expression in model organisms has many applications, including protein engineering, production of industrial enzymes and…
Identifying genome-wide targets of osmotic stress tolerance in E. coli using CRISPR-mediated forward engineering
September 13, 2021
Biological responses to environmental stress can arise from multiple genetic solutions encoding tolerance mechanisms. In order to investigate the…